| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5614766 | Journal of Cardiology | 2017 | 8 Pages |
Abstract
Compared with diet and exercise therapy, sitagliptin did not significantly reduce coronary PV in diabetic patients with ACS at 6-month follow-up. However, the percent change in lipid PV significantly decreased in the sitagliptin group, suggesting that sitagliptin has a potential to stabilize the plaque vulnerability.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shoichi MD, Katsumi MD, FJCC, Hiroyoshi MD, Satoru MD, Yuji MD, PhD, MPH, Takayuki MD, PhD, Shuko PhD, Masashi MD, Shinichi MD, Kenji MD, Shinya MD, Hiroshi MD, Hirotaka MD, PhD, Hiroyuki MD, FJCC,